CovalX
Zurich, CH · 1 known investors
CovalX provides mass spectrometry-based analytical services for biotherapeutic development, including epitope mapping, de novo sequencing, and monoclonal antibody characterization. It serves pharmaceutical and biotechnology companies across Europe and the United States, supporting drug discovery and development.
Investors · 1
Frequently asked questions
- What does CovalX do?
- CovalX provides mass spectrometry-based analytical services for biotherapeutic development, including epitope mapping, de novo sequencing, and monoclonal antibody characterization. It serves pharmaceutical and biotechnology companies across Europe and the United States, supporting drug discovery and development.
- Who are CovalX's investors?
- CovalX's investors include StartAngels Network.
- Where is CovalX headquartered?
- CovalX is headquartered in Zurich, CH.